Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-12

FDA Approved: ESCITALOPRAM OXALATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for escitalopram oxalate, a generic version of the antidepressant, for treating major depressive disorder and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

ORIG AP for ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)